Top Tech Companies (144)
We use cutting-edge gene editing techniques to develop healthier, hardier and more sustainable crop varieties that flourish even in the face of climate change so local growing communities can thrive, and we can sustain the world’s food supply
Tailor Bio is developing an AI-driven drug discovery platform for pan-cancer precision medicine. We're doing this by focussing on Chromosomal Instability, a genomic phenomenon present in 80% of all cancers.
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders
MultiplAI Health is a preventive medicine company pioneering blood screening for cardiovascular and other complex diseases. Powered by genomic RNAseq, proprietary data transformation, and comprehensive AI analysis, our test transforms a single blood sample into a precision, actionable risk assessment to drive proactive health management that will extend lifespan. We have a laboratory-validated prototype and are conducting our sixth clinical...
Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for...
Eternal is solving the absence of a properly sustainable and cost-effective protein ingredient that is flavor neutral. The company uses AI and computer vision to improve the fungi fermentation techniques of existing and approved strains. The result is a market-ready product that suits better the needs of a range of food manufacturers, reducing the amount of post processing needed for...
SIME is a clinical AI company applying medical excellence, proprietary AI and data ingenuity to deliver rapid respiratory intensive care diagnostics for acute unmet needs. Our clinically proven technology enables early intervention in life-threatening diseases - improving outcomes and reducing costs.
At Convergence, our mission is to build a future of abundance for all of humanity. We are developing the first generation of truly general agents that can pick up any skill by actively working and learning from experience.
MicrofluidX presents the Cyto Engine, a unified bioreactor and data platform for cell and gene therapy research, development, and manufacturing
BioPhorum’s mission is to create environments where the global biopharmaceutical and device industry can collaborate and accelerate its rate of progress, for the benefit of all. A business-to-business membership organization, BioPhorum consists of twelve phorums leading industry-changing initiatives with the help of thousands of active subject matter experts. Established in 2008, we bring leaders and subject matter experts together to...
IAG, Image Analysis Group is a unique partner to life sciences companies, leading AI-powered drug development and precision medicine. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and...
The brain is central to every aspect of our lives, yet it isn’t monitored with the same consistency and proactivity as other vital signs. As a neuroscience technology company, we believe that better brain health insights lead to better brain health outcomes. That's why we're on a mission to democratize cognitive health by radically simplifying the way it is measured. For...
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options. Our most advanced therapy is VRB-101, an oral GLP-1 peptide in clinical development that has demonstrated best-in-class efficacy potential in a phase 1 study in Australia, which also confirmed the viability of once-weekly...
Personalised cancer therapeutics platform pioneered at Mount Sinai Medical Center
Modern Synthesis is a London based biomaterial company connecting the dots between biology, material science and design to craft the next generation of biomaterials for the fashion industry
Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects.
LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics.
Talent experts providing scalable, bespoke recruitment solutions for growing Life Science companies. We have experienced teams of recruiters who can advise and hire across all areas within: • Pharmaceutical • Biotechnology • CRO Services • Health Technology • Medical Devices Our services include contingent, retained, and embedded services, our own version of scaled RPO – suited to rapidly growing organisations....
Causaly amplifies human cognitive abilities to expand the boundaries of discovery towards making the best decisions in Biomedicine. To achieve this, we are teaching computers to read all knowledge ever published and develop an interface that allows humans to answer questions they can’t ask anywhere else.
An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions. Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working...
